BIOTECH STOCKS WORTH A CLOSER LOOK: CATALYST BIOSCIENCES, INC. (NASDAQ:CBIO), NAVIDEA BIOPHARMACEUTICALS, INC (NYSEMKT:NAVB)
Cardinal Health | January 02, 2017
Shares of Catalyst Biosciences, Inc. (NASDAQ:CBIO) dropped -16.46% by the end of trading session at $0.73. For the current quarter, the 2 brokerage firms issuing adjusted earnings per share outlook have a consensus forecast of -$0.38/share, which would compare with -$0.98 in the year-ago quarter. The net percentage change is -63.66% over the last 12 months. The trading range in the same period had a highest hit of $4.57 while lowest level was $0.53. At the moment the price is -8.05% below its 50-day moving average and -44.07% below its 200-day moving average.